Clinical Trials on Recurrent Intraocular Melanoma
Total 9719 results
-
National Cancer Institute (NCI)Withdrawn
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
New England Retina AssociatesCompletedChoroidal MelanomaUnited States
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
University Hospital, CaenCompleted
-
New England Retina AssociatesGenentech, Inc.CompletedChoroidal MelanomaUnited States
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
Assistance Publique Hopitaux De MarseilleUnknownMelanoma CancerFrance
-
Hoffmann-La RocheCompleted
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
Hoag Memorial Hospital PresbyterianCompletedMetastatic MelanomaUnited States
-
Centre Oscar LambretNovartis; National Cancer Institute, FranceTerminated
-
Eisai Inc.Completed
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
Duke UniversityTerminatedMetastatic MelanomaUnited States
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
University of Massachusetts, WorcesterCompleted
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
Prof. Dr. med. Dirk SchadendorfCompletedOcular MelanomaGermany
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
CancerVax CorporationUnknownMelanoma (Skin)United States, Australia
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
California Pacific Medical Center Research InstituteCompletedMetastatic MelanomaUnited States
-
Maria Sklodowska-Curie National Research Institute...Unknown
-
Millennium Pharmaceuticals, Inc.Completed
-
New England Retina AssociatesCompleted
-
University Hospital TuebingenGerman Research FoundationCompleted
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
AstraZenecaCompleted
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Pain TherapeuticsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMelanoma (Skin)
-
Peking UniversityNovartisCompletedMetastatic MelanomaChina
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)No longer available
-
Charite University, Berlin, GermanyUnknown
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University of TurkuCompletedMetastatic MelanomaFinland
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedStage IV Uveal Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal MelanomaUnited States
-
XinWuRecruitingMetastatic or Recurrent Gynecological TumorsChina
-
National Taiwan University HospitalUnknown
-
TopLab Company for ART Laboratories Consultation...CompletedRecurrent Implantation Failure (RIF)